Epigenetic alterations impede epithelial-mesenchymal transition by modulating centrosome amplification and Myc/RAS axis in triple negative breast cancer cells

• Published in: Scientific reports 2023-02, Vol.13 (1), p.2458-2458, Article 2458
• Main Author: Das, Laxmidhar
• Format: Article
• Language: English
• Subjects: 631/337; 631/45; 631/67; 631/80; 692/4028; Adenocarcinoma; Aneuploidy; Apoptosis; BAX protein; Breast cancer; Breast Neoplasms - pathology; Cadherins - genetics; Cadherins - metabolism; Cell growth; Cell Line, Tumor; Cell proliferation; Centrosome - metabolism; Centrosomes; Chromatin remodeling; Deacetylation; DNA methylation; DNMT1 protein; E-cadherin; Epigenesis, Genetic; Epigenetics; Epithelial-Mesenchymal Transition - genetics; Female; Genomic instability; HDAC2 protein; Histone deacetylase; Histones; Humanities and Social Sciences; Humans; Mesenchyme; Metastases; multidisciplinary; Myc protein; N-Cadherin; Nuclear transport; Science; Science (multidisciplinary); siRNA; Spindles; Translocation; Triple Negative Breast Neoplasms - pathology; Tubulin
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-023-29712-8

Alterations in centrosome proteins may result in centrosome abnormalities such as disorganized spindles and centrosome amplification, leading to aneuploidy and genomic instability. Centrosomes exhibit unique epigenetic properties in which structural or positional information is propagated through somatic lineage by non-genetic pathways. Excessive centrosome amplification in breast cancer is accompanied by efficient clustering and loss of E-cadherin, indicating an important adaptive mechanism of cancer. This study sought to elucidate the effect of epigenetic alterations on centrosome amplification, epithelial-mesenchymal transition (EMT) and apoptosis in triple negative human breast adenocarcinoma derived MDA-MB-231 cell line. The results obtained here show that siRNA mediated silencing of DNMT1 and specific inhibition of HDAC1 & HDAC2 by Tricostatin A (TSA) synergistically inhibit cell proliferation through modulation of centrosome proteins γ-tubulin, TUBGCP2 and pericentrin. In addition, induction of apoptosis was observed by downregulation of Bcl2, upregulation of Bax and activation of PARP cleavage. Inhibition of EMT was confirmed through upregulation of E-cadherin and downregulation of N-cadherin and vimentin. Similarly, downregulation of Myc, RAS and CDK2, which plays important roles in proliferation and survival, was observed. Nuclear protein analysis revealed downregulation in the nuclear translocation of E2F1, which regulates centrosome amplification and metastasis in breast cancer. In conclusion, this study confirmed the role of epigenetic regulators in centrosome amplification and suggests that inhibition of DNA methylation and histone deacetylation-mediated chromatin remodelling synergistically disrupt EMT through modulation of centrosome amplification and Myc/RAS axis to potentiate apoptosis and attenuate cell proliferation in triple negative breast cancer cells.